• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特应性皮炎评估和管理的现行指南:联合工作组实践参数和美国皮肤病学会指南的比较。

Current guidelines for the evaluation and management of atopic dermatitis: A comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelines.

机构信息

Department of Pediatric and Adolescent Dermatology, Rady Children's Hospital, San Diego, Calif; Department of Pediatric and Adolescent Dermatology, University of California, San Diego School of Medicine, La Jolla, Calif.

Department of Pediatric and Adolescent Dermatology, Rady Children's Hospital, San Diego, Calif; Department of Pediatric and Adolescent Dermatology, University of California, San Diego School of Medicine, La Jolla, Calif.

出版信息

J Allergy Clin Immunol. 2017 Apr;139(4S):S49-S57. doi: 10.1016/j.jaci.2017.01.009.

DOI:10.1016/j.jaci.2017.01.009
PMID:28390477
Abstract

Atopic dermatitis (AD) is a chronic pruritic inflammatory disease that commonly presents in the pediatric population. Although definitions and diagnosis of AD have largely been agreed upon, allergists and dermatologists have similar and divergent approaches to the management of AD. This review facilitated integration of the American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma & Immunology Joint Task Force 2012 AD Practice Parameter and the 2014 American Academy of Dermatology guidelines to highlight the basic principles of AD management and discuss therapies and management of AD from the distinct perspectives of the allergist and dermatologist.

摘要

特应性皮炎(AD)是一种常见于儿童的慢性瘙痒性炎症性疾病。尽管 AD 的定义和诊断已基本达成共识,但过敏学家和皮肤科医生在 AD 的治疗方法上存在相似和不同的方法。本综述有助于整合美国过敏、哮喘和免疫学会/美国过敏、哮喘和免疫学会联合工作组 2012 年 AD 实践参数和 2014 年美国皮肤病学会指南,强调 AD 管理的基本原则,并从过敏学家和皮肤科医生的不同角度讨论 AD 的治疗方法和管理。

相似文献

1
Current guidelines for the evaluation and management of atopic dermatitis: A comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelines.特应性皮炎评估和管理的现行指南:联合工作组实践参数和美国皮肤病学会指南的比较。
J Allergy Clin Immunol. 2017 Apr;139(4S):S49-S57. doi: 10.1016/j.jaci.2017.01.009.
2
Comparison of Dermatology and Allergy Guidelines for Atopic Dermatitis Management.特应性皮炎管理的皮肤病学和过敏学指南比较。
JAMA Dermatol. 2015 Sep;151(9):1009-13. doi: 10.1001/jamadermatol.2015.0250.
3
Disease management of atopic dermatitis: a practice parameter. Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. Work Group on Atopic Dermatitis.特应性皮炎的疾病管理:实践参数。实践参数联合工作组,代表美国过敏、哮喘与免疫学会、美国过敏、哮喘与免疫学院以及过敏、哮喘与免疫联合委员会。特应性皮炎工作组。
Ann Allergy Asthma Immunol. 1997 Sep;79(3):197-211. doi: 10.1016/s1081-1206(10)63003-7.
4
Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations.特应性皮炎(湿疹)指南:2023 年美国过敏、哮喘和免疫学学会/美国过敏、哮喘和免疫学学会联合工作组关于实践参数的推荐意见,基于 GRADE 分级和医学研究所的建议。
Ann Allergy Asthma Immunol. 2024 Mar;132(3):274-312. doi: 10.1016/j.anai.2023.11.009. Epub 2023 Dec 18.
5
Patterns of clinical management of atopic dermatitis in infants and toddlers: a survey of three physician specialties in the United States.婴幼儿特应性皮炎的临床管理模式:对美国三个医师专业的调查。
J Pediatr. 2013 Dec;163(6):1747-53. doi: 10.1016/j.jpeds.2013.06.073. Epub 2013 Aug 15.
6
Updated Guidelines for Atopic Dermatitis-AAAAI/ACAAI Joint Task Force.特应性皮炎更新指南——美国过敏、哮喘与免疫学会/美国过敏、免疫与哮喘学会联合工作组
JAMA Pediatr. 2024 Oct 1;178(10):961-962. doi: 10.1001/jamapediatrics.2024.1395.
7
Atopic dermatitis: a practice parameter update 2012.特应性皮炎:2012 年实践参数更新。
J Allergy Clin Immunol. 2013 Feb;131(2):295-9.e1-27. doi: 10.1016/j.jaci.2012.12.672.
8
Diagnosis and management of moderate to severe atopic dermatitis in adolescents. A Consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Italian Association of Hospital Dermatologists and Public Health (ADOI), the Italian Association of Hospital and Territorial Allergists and Immunologists (AAIITO), the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), the Italian Society of Pediatric Allergy and Immunology (SIAIP), the Italian Society of Allergological, Occupational and Environmental Dermatology (SIDAPA), and the Italian Society of Pediatric Dermatology (SIDerP).青少年中重度特应性皮炎的诊断与管理。意大利皮肤病与性病学会(SIDeMaST)、意大利医院皮肤科医生与公共卫生协会(ADOI)、意大利医院与地区过敏症专家及免疫学家协会(AAIITO)、意大利过敏、哮喘与临床免疫学学会(SIAAIC)、意大利儿科过敏与免疫学学会(SIAIP)、意大利变应性、职业性与环境性皮肤病学会(SIDAPA)以及意大利儿科皮肤病学会(SIDerP)达成的共识。
Ital J Dermatol Venerol. 2021 Apr;156(2):184-197. doi: 10.23736/S2784-8671.20.06654-7. Epub 2020 May 21.
9
Dermatologists and allergists have far more experience and use more complex treatment regimens in the treatment of atopic dermatitis than other physicians.皮肤科医生和过敏症专科医生在治疗特应性皮炎方面比其他医生有更多经验,且使用更复杂的治疗方案。
J Cutan Med Surg. 2001 May-Jun;5(3):211-6. doi: 10.1007/s10227-001-0002-4. Epub 2001 May 17.
10
[The management of atopic dermatitis in children by dermatologists, paediatricians, general practitioners and allergologists: a national survey on practice patterns].皮肤科医生、儿科医生、全科医生和过敏症专科医生对儿童特应性皮炎的管理:一项关于实践模式的全国性调查
Ann Dermatol Venereol. 2005 Jan;132 Spec No 1:1S283-95.

引用本文的文献

1
Therapeutic potential of cannabinoids for treating atopic dermatitis.大麻素治疗特应性皮炎的潜在疗效。
J Cannabis Res. 2025 Aug 16;7(1):57. doi: 10.1186/s42238-025-00317-4.
2
Innovative microbial strategies in atopic dermatitis.特应性皮炎中的创新微生物策略。
Front Immunol. 2025 Jul 23;16:1605434. doi: 10.3389/fimmu.2025.1605434. eCollection 2025.
3
Quality of Care of Adult Patients With Allergic Diseases in Urban, Rural, and Remote Primary Care Sites in the Philippines.菲律宾城市、农村和偏远地区基层医疗点成年过敏疾病患者的医疗质量
J Prim Care Community Health. 2025 Jan-Dec;16:21501319251353599. doi: 10.1177/21501319251353599. Epub 2025 Jul 16.
4
Efficacy and Safety of Haidebao Body Lotion in Patients With Mild Atopic Dermatitis: Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial.海德宝身体乳治疗轻度特应性皮炎患者的疗效与安全性:一项多中心、双盲、随机、安慰剂对照试验的方案
JMIR Res Protoc. 2025 Jun 10;14:e71255. doi: 10.2196/71255.
5
Exploring the Mechanism of Qinzhuliangxue Mixture for Treating Skin Lesions in Atopic Dermatitis: Insights from Network Pharmacology and Experimental Validation.探索芩珠凉血合剂治疗特应性皮炎皮肤损伤的机制:来自网络药理学和实验验证的见解
J Inflamm Res. 2025 Apr 16;18:5173-5187. doi: 10.2147/JIR.S509607. eCollection 2025.
6
Maximal Usage Trial of Tapinarof Cream 1% Once Daily in Pediatric Patients Down to 2 Years of Age with Extensive Atopic Dermatitis.1% 他扎罗汀乳膏每日一次用于2岁及以下广泛性特应性皮炎儿科患者的最大用量试验。
Am J Clin Dermatol. 2025 May;26(3):449-456. doi: 10.1007/s40257-025-00929-9. Epub 2025 Mar 24.
7
and efficacy of the Active Oligo Skin complex™, a new active ingredient processed from seawater, on multiple parameters of atopic skin.以及从海水中提取的新型活性成分“活性低聚糖皮肤复合物™”对特应性皮肤多个参数的功效。
Skin Health Dis. 2025 Feb 14;5(1):22-30. doi: 10.1093/skinhd/vzae029. eCollection 2025 Feb.
8
2023 Consensus Korean Diagnostic Criteria for Atopic Dermatitis.2023年韩国特应性皮炎诊断标准共识
Ann Dermatol. 2025 Feb;37(1):12-21. doi: 10.5021/ad.24.049.
9
Atopic dermatitis: pathogenesis and therapeutic intervention.特应性皮炎:发病机制与治疗干预
MedComm (2020). 2024 Dec 8;5(12):e70029. doi: 10.1002/mco2.70029. eCollection 2024 Dec.
10
Treatment of Atopic Dermatitis in Children.儿童特应性皮炎的治疗
Cureus. 2024 Sep 14;16(9):e69416. doi: 10.7759/cureus.69416. eCollection 2024 Sep.